Daily oral Dimethandrolone Undecanote (DMAU) is a formulation that aims to become the first male birth control pill. Its active ingredient, DMAU, is hydrolyzed to DMA, a novel derivative of 19-nortestosterone that binds to both the androgen and the progesterone receptors, making it an attractive candidate as a single-agent male contraceptive.
For more information: https://clinicaltrials.gov/ct2/show/NCT01382069
Of note, Los Angeles (CA, USA) and Seattle (WA, USA) are both recruiting participants for a trial on a DMAU injection. For more information, please see: https://clinicaltrials.gov/ct2/show/NCT02927210